Sebastian Giebel Selected Research

Tyrosine Kinase Inhibitors

1/2021	Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party.
1/2019	Post-remission strategies for the prevention of relapse following allogeneic hematopoietic cell transplantation for high-risk acute myeloid leukemia: expert review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
1/2018	Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of the EBMT.
10/2016	Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sebastian Giebel Research Topics

Disease

55	Leukemia 01/2022 - 10/2006
39	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2022 - 02/2002
26	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022 - 02/2008
21	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 08/2003
11	Neoplasms (Cancer) 01/2022 - 08/2003
10	Lymphoma (Lymphomas) 01/2021 - 08/2003
9	Multiple Myeloma 01/2021 - 06/2011
6	Bronchiolitis Obliterans Syndrome 01/2021 - 01/2006
6	Infections 01/2019 - 02/2002
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2021 - 01/2006
5	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 10/2009
4	Philadelphia Chromosome 01/2021 - 10/2016
4	Residual Neoplasm 04/2020 - 06/2016
3	Neutropenia 01/2022 - 06/2006
3	Hodgkin Disease (Hodgkin's Disease) 07/2021 - 01/2021
3	Rheumatoid Arthritis 08/2010 - 01/2002
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2006 - 01/2006
2	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2021
2	Disease Progression 07/2021 - 06/2014
2	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 10/2020 - 01/2005
2	Inflammation (Inflammations) 10/2020 - 01/2002
2	Thrombosis (Thrombus) 10/2020 - 11/2008
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2020 - 02/2012
2	Systemic Scleroderma (Systemic Sclerosis) 12/2017 - 08/2003
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2016 - 08/2003
1	Viremia 02/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	Anemia 01/2021
1	COVID-19 01/2021
1	Skin Neoplasms (Skin Cancer) 10/2020
1	Hemolysis 10/2020
1	Hemorrhage 01/2020
1	Bites and Stings (Sting) 01/2020

Drug/Important Bio-Agent (IBA)

15	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022 - 10/2006
12	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2006
7	fludarabineIBA 01/2022 - 10/2006
7	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2021 - 08/2003
7	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2019 - 02/2002
6	Cladribine FDA LinkGeneric 08/2021 - 02/2008
4	Etoposide (VP 16)FDA LinkGeneric 01/2022 - 01/2018
4	Dexamethasone (Maxidex)FDA LinkGeneric 07/2021 - 01/2016
4	Tyrosine Kinase InhibitorsIBA 01/2021 - 10/2016
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022 - 08/2003
3	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 01/2022 - 01/2017
3	Busulfan (Busulfex)FDA Link 01/2022 - 01/2021
3	Bendamustine Hydrochloride FDA Link 07/2021 - 12/2018
3	Melphalan (Alkeran)FDA LinkGeneric 01/2021 - 01/2018
3	SteroidsIBA 02/2020 - 01/2005
3	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2020 - 10/2006
3	treosulfanIBA 09/2011 - 01/2006
2	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 08/2003
2	Azacitidine (5 Azacytidine)FDA Link 07/2021 - 01/2019
2	Gemcitabine FDA Link 07/2021 - 07/2021
2	Carmustine (FIVB)FDA Link 01/2021 - 01/2018
2	Rituximab (Mabthera)FDA Link 12/2018 - 01/2018
2	InterferonsIBA 04/2015 - 06/2006
2	LigandsIBA 06/2014 - 08/2003
2	Daunorubicin (Cerubidine)FDA LinkGeneric 07/2012 - 02/2010
2	Pharmaceutical PreparationsIBA 11/2008 - 06/2006
2	Prednisolone (Predate)FDA LinkGeneric 01/2006 - 01/2005
1	itacitinibIBA 01/2022
1	ofatumumab FDA Link 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Amsacrine (AMSA)IBA 01/2022
1	Ifosfamide FDA LinkGeneric 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 11/2021
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 11/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	GlucocorticoidsIBA 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	ruxolitinibIBA 01/2021
1	daratumumabIBA 01/2021
1	Azathioprine (Imuran)FDA LinkGeneric 10/2020
1	blinatumomabIBA 04/2020
1	montelukast (Singulair)FDA Link 02/2020
1	Fluticasone (Cutivate)FDA LinkGeneric 02/2020
1	GlobulinsIBA 02/2020
1	Thomsen-Friedenreich antibodiesIBA 02/2020
1	Azithromycin (Zithromax)FDA LinkGeneric 02/2020
1	AntibodiesIBA 01/2020
1	antineoplaston A10 (A 10)IBA 01/2020

Therapy/Procedure

43	Transplantation 10/2022 - 01/2005
37	Hematopoietic Stem Cell Transplantation 01/2022 - 08/2003
27	Stem Cell Transplantation 10/2022 - 08/2003
27	Cell Transplantation 03/2022 - 01/2006
20	Drug Therapy (Chemotherapy) 01/2022 - 02/2002
20	Therapeutics 01/2022 - 02/2002
4	Haploidentical Transplantation 01/2021 - 11/2017
3	Radiotherapy 10/2020 - 04/2015
3	Homologous Transplantation 10/2019 - 01/2017
3	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2019 - 01/2017
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2018 - 01/2005
2	Salvage Therapy 01/2022 - 07/2021
2	Hematopoietic Stem Cell Mobilization 01/2016 - 06/2011
1	Traction 01/2021
1	Donor Selection 01/2021
1	Investigational Therapies (Experimental Therapy) 01/2021
1	Immunotherapy 01/2021
1	Erythrocyte Transfusion 10/2020